Sectoral Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,081
| Closed | -$248K | – | 101 |
|
|
2024
Q1 | $248K | Sell |
12,081
-800
| -6% | -$16.4K | 0.1% | 86 |
|
|
2023
Q4 | $276K | Sell |
12,881
-242,060
| -95% | -$5.19M | 0.12% | 95 |
|
|
2023
Q3 | $5.26M | Buy |
254,941
+9,650
| +4% | +$199K | 1.02% | 38 |
|
|
2023
Q2 | $7.24M | Buy |
245,291
+441
| +0.2% | +$13K | 1.21% | 32 |
|
|
2023
Q1 | $5.64M | Buy |
244,850
+1,000
| +0.4% | +$23K | 1.08% | 36 |
|
|
2022
Q4 | $6.78M | Buy |
243,850
+500
| +0.2% | +$13.9K | 1.31% | 23 |
|
|
2022
Q3 | $7.47M | Buy |
243,350
+41,250
| +20% | +$1.27M | 1.47% | 22 |
|
|
2022
Q2 | $5.95M | Sell |
202,100
-5,000
| -2% | -$147K | 1.2% | 32 |
|
|
2022
Q1 | $6.66M | Buy |
207,100
+17,500
| +9% | +$563K | 1.18% | 33 |
|
|
2021
Q4 | $8.46M | Buy |
189,600
+62,100
| +49% | +$2.77M | 1.27% | 32 |
|
|
2021
Q3 | $6.43M | Buy |
127,500
+62,500
| +96% | +$3.15M | 0.53% | 77 |
|
|
2021
Q2 | $5.1M | Buy |
65,000
+61,000
| +1,525% | +$4.79M | 0.41% | 86 |
|
|
2021
Q1 | $228K | Buy |
+4,000
| New | +$228K | 0.02% | 112 |
|
|
2020
Q3 | – | Sell |
-9,600
| Closed | -$232K | – | 114 |
|
|
2020
Q2 | $232K | Buy |
+9,600
| New | +$232K | 0.02% | 175 |
|